Bioelectronics Corp  

(Public, OTCMKTS:BIEL)   Watch this stock  
Find more results for John Whelan
-0.00009 (-6.00%)
Delayed:   11:08AM EST
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 0.01
Open 0.00
Vol / Avg. 356,443.00/10.99M
Mkt cap 8.77M
P/E     -
Div/yield     -
EPS     -
Shares 6.22B
Beta -2.33
Inst. own 0%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -312.92% -367.48%
Operating margin -245.43% -290.53%
EBITD margin - -288.05%
Return on average assets -341.38% -260.57%
Return on average equity - -
Employees 9 -
CDP Score - -


4539 Metropolitan Court
United States - Map
+1-301-8744890 (Phone)
+1-301-8746935 (Fax)

Website links


BioElectronics Corporation is a development-stage company. The Company is the developer, marketer and manufacturer of patented, drug free, topical pain medical devices. The devices use proven therapies of heat and electric restoration of the body�s injured cells.The devices consist of an inexpensive microchip, battery and antenna that deliver the therapy. The Company markets and sells its products under the brand names ActiPatch, Allay and RecoveryRx.

Officers and directors

Richard Staelin Ph.D. Chairman of the Board
Age: 68
Andrew J. Whelan President, Chief Executive Officer, Director
Age: 66
William Monn Vice President - Production
Ben Fichter Marketing Manager
John M. Martinez Senior Engineer
Ian Rawe Director - Clinical Research
Mary K Whelan Director
Age: 57